A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This extension study was a 24-week off-drug follow-up of the core CBYM338E2202 (NCT ) study and the main objective was to determine the long-term durability of bimagrumab (BYM338) effect after a 6-month treatment period.
Epistemonikos ID: 4a935e59b58aeb3a78b73e37aa3858ca31335718
First added on: May 12, 2024